A new meta-analysis suggests omega-3 supplement consumption is associated with a 58% decrease in the likelihood of early preterm birth.
Photo © iStockphoto.com/leventince
Studies has suggested omega-3s may play a vital role in infant health, both before and after birth, but a new meta-analysis has found that omega-3 supplementation may reduce the likelihood of early preterm birth by 58%.
In addition to reducing the chance of early preterm birth (defined as babies born before 34 weeks), omega-3 supplementation was associated with a 17% decrease in any preterm delivery (babies born before 37 weeks). Researchers also found a significantly longer gestation period and significantly higher average infant birth weight in the omega-3 group compared to controls.
“This research underscores much of what we already knew about the importance of EPA and DHA for infant development, and it builds on research that strongly suggests these omega-3s are a key to health throughout life,” said Harry Rice, PhD, vice president of regulatory and scientific affairs, GOED. “Experts know that carrying a baby full-term strongly increases the likelihood of a healthy baby post-delivery, which means omega-3 consumption is crucial for pregnant women.”
The systematic review and meta-analysis included 4193 women from six randomized studies.
“Omega-3 fatty acids are effective in preventing early and any preterm delivery,” concluded researchers. “The intervention is simple and easily available, and has the potential to influence population-based strategies in the prevention of preterm birth.”
Read more:
New Breakthroughs in Omega-3 Research
GOED’s New Omega-3 Website Targets Consumers, Market Recovery
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Kar S et al., “Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 198 (November 2015): 40–46
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.